Search
Menu
Home
HTB
2002
June
HTB
June 2002
Contents
Conference reports
9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Februrary 24-28 2002
New research points the way for future treatment of women with HIV
3rd International Workshop on Clinical Pharmacology of HIV Therapy, Washington, 11-13 April 2002
Three studies compare gender differences in use of antiretrovirals
Antiretrovirals
Amprenavir mutations may significantly affect LPV resistance
24-week results from phase III study of HIV fusion inhibitor T-20
Abacavir treatment limited by prior NRTI exposure
Treatment access
WHO releases guidelines for use of antiretroviral drugs to treat HIV infection in developing countries (2002)
Mbeki backs down: he shuns dissidents and expands drug treatment programme
Early access programme offers adefovir for treatment of HBV
Paediatric care
CCR5 density on CD4 cells governs course of HIV infection in children
Saquinavir is a suboptimal treatment for children unless used in combination
Guidelines
First audit of BHIVA treatment guidelines reveals suboptimal access to viral load and resistance tests
Side effects
Neuropsychiatric complications of nevirapine treatment
Paracardial fat in HIV-infected patient resembles pericardial effusion
Coinfections and complications
Filgrastim seems to increase survival in AIDS patients but the mechanism remains unclear
Oral valganciclovir is as effective as intravenous ganciclovir for induction treatment of CMV retinitis
Basic science and immunology
Measles found to suppress HIV
Drug resistance
Resistance mutations continue to accumulate with low-level viral increases
Resistance to template-analogue inhibitors linked to impaired replication
Other news
New cancer drugs might help treat HIV — but research not done
First report of acquired HCV immunity lifts vaccine hopes
Manganese blocks HIV replication; lab finding points to a potential new class of HIV treatments
Turmeric may slow multiple sclerosis progression
1,500 community representatives expected at Barcelona community forum
On the web
Fibrates and statins and glitazones (oh my!)
Nutrition and immunity: you are what you eat
The role of dietary supplements in HIV
Using evidence to make nutrition decisions: a look at zinc
Peripheral neuropathy
A potent weapon in the battle against HIV: your own immune system
PDFs
Volume 3 Number 5 June 2002 PDF
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate